CymaBay Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2014 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CymaBay Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2014 to Q4 2023.
  • CymaBay Therapeutics, Inc. Return On Assets for the quarter ending December 31, 2023 was -31 %, a 50.3% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Return On Assets for 2023 was -31 %, a 50.3% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Return On Assets for 2022 was -62.4 %, a 0.35% decline from 2021.
  • CymaBay Therapeutics, Inc. annual Return On Assets for 2021 was -62.2 %, a 110% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -31 +31.4 +50.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -33.8 +23.4 +40.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -41.8 +17.4 +29.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -59.1 +3.24 +5.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -62.4 -0.22 -0.35% Oct 1, 2022 Dec 31, 2022
Q3 2022 -57.3 +2.47 +4.14% Jul 1, 2022 Sep 30, 2022
Q2 2022 -59.2 -12 -25.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -62.4 -27.5 -78.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -62.2 -32.5 -110% Oct 1, 2021 Dec 31, 2021
Q3 2021 -59.7 -24.8 -70.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -47.2 -7.56 -19.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -34.9 +7.32 +17.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -29.7 +13 +30.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -35 +4.28 +10.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -39.6 -2.53 -6.82% Apr 1, 2020 Jun 30, 2020
Q1 2020 -42.2 -6.59 -18.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -42.6 -8.1 -23.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -39.3 -8.59 -28% Jul 1, 2019 Sep 30, 2019
Q2 2019 -37.1 -8.07 -27.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -35.6 -1.5 -4.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -34.5 +9.11 +20.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -30.7 +39.6 +56.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -29 +93.9 +76.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -34.1 +66.6 +66.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -43.6 +52.2 +54.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -70.2 +5.85 +7.69% Jul 1, 2017 Sep 30, 2017
Q2 2017 -123 -58.3 -90.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 -101 -49.7 -97.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -95.8 -55.8 -140% Oct 1, 2016 Dec 31, 2016
Q3 2016 -76.1 -16.6 -27.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -64.5 -3.05 -4.96% Apr 1, 2016 Jun 30, 2016
Q1 2016 -51 +16.7 +24.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -40 +51.6 +56.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -59.5 +9.29 +13.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -61.5 -0.92 -1.52% Apr 1, 2015 Jun 30, 2015
Q1 2015 -67.7 Jan 1, 2015 Mar 31, 2015
Q4 2014 -91.6 Oct 1, 2014 Dec 31, 2014
Q3 2014 -68.8 Jul 1, 2014 Sep 30, 2014
Q2 2014 -60.6 Apr 1, 2014 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.